CN113355359A - 一种高效生产类克隆鸡的方法 - Google Patents
一种高效生产类克隆鸡的方法 Download PDFInfo
- Publication number
- CN113355359A CN113355359A CN202110654978.XA CN202110654978A CN113355359A CN 113355359 A CN113355359 A CN 113355359A CN 202110654978 A CN202110654978 A CN 202110654978A CN 113355359 A CN113355359 A CN 113355359A
- Authority
- CN
- China
- Prior art keywords
- cells
- pgc
- chicken
- feather
- induction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000287828 Gallus gallus Species 0.000 title claims abstract description 61
- 238000000034 method Methods 0.000 title claims abstract description 31
- 235000013330 chicken meat Nutrition 0.000 claims abstract description 60
- 210000004027 cell Anatomy 0.000 claims abstract description 59
- 230000006698 induction Effects 0.000 claims abstract description 32
- 210000003746 feather Anatomy 0.000 claims abstract description 21
- 239000001963 growth medium Substances 0.000 claims abstract description 18
- 230000012447 hatching Effects 0.000 claims abstract description 17
- 210000003837 chick embryo Anatomy 0.000 claims abstract description 14
- 210000004204 blood vessel Anatomy 0.000 claims abstract description 12
- 238000005516 engineering process Methods 0.000 claims abstract description 11
- 239000002609 medium Substances 0.000 claims abstract description 11
- 210000002950 fibroblast Anatomy 0.000 claims abstract description 10
- 230000001939 inductive effect Effects 0.000 claims abstract description 10
- 101000984042 Homo sapiens Protein lin-28 homolog A Proteins 0.000 claims abstract description 5
- 101000687905 Homo sapiens Transcription factor SOX-2 Proteins 0.000 claims abstract description 5
- 108091092878 Microsatellite Proteins 0.000 claims abstract description 5
- 102100025460 Protein lin-28 homolog A Human genes 0.000 claims abstract description 5
- 102100024270 Transcription factor SOX-2 Human genes 0.000 claims abstract description 5
- 239000013604 expression vector Substances 0.000 claims abstract description 5
- 230000002018 overexpression Effects 0.000 claims abstract description 5
- 241000713666 Lentivirus Species 0.000 claims abstract description 4
- 238000002347 injection Methods 0.000 claims abstract description 4
- 239000007924 injection Substances 0.000 claims abstract description 4
- 241000282461 Canis lupus Species 0.000 claims abstract description 3
- 238000010276 construction Methods 0.000 claims abstract description 3
- 238000010166 immunofluorescence Methods 0.000 claims description 10
- 238000010186 staining Methods 0.000 claims description 10
- 210000001161 mammalian embryo Anatomy 0.000 claims description 9
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 8
- 235000013601 eggs Nutrition 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 229920002527 Glycogen Polymers 0.000 claims description 6
- 229940096919 glycogen Drugs 0.000 claims description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 6
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 4
- 229930192392 Mitomycin Natural products 0.000 claims description 4
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 claims description 4
- 230000013011 mating Effects 0.000 claims description 4
- 229960004857 mitomycin Drugs 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- 230000001568 sexual effect Effects 0.000 claims description 4
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 claims description 3
- 101000762379 Homo sapiens Bone morphogenetic protein 4 Proteins 0.000 claims description 3
- -1 NANOG Proteins 0.000 claims description 3
- 229960005322 streptomycin Drugs 0.000 claims description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 230000004069 differentiation Effects 0.000 claims 1
- 230000002068 genetic effect Effects 0.000 abstract description 2
- 238000001890 transfection Methods 0.000 abstract 1
- 210000001082 somatic cell Anatomy 0.000 description 8
- 238000003822 preparative gas chromatography Methods 0.000 description 7
- 239000011148 porous material Substances 0.000 description 6
- 244000144977 poultry Species 0.000 description 6
- 235000013594 poultry meat Nutrition 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 108010076089 accutase Proteins 0.000 description 5
- 230000008672 reprogramming Effects 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 241000717544 Aconitum lycoctonum subsp. vulparia Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000010370 cell cloning Methods 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 229920000209 Hexadimethrine bromide Polymers 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 210000004602 germ cell Anatomy 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- LAQPKDLYOBZWBT-NYLDSJSYSA-N (2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 description 1
- QTENRWWVYAAPBI-YZTFXSNBSA-N Streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@H]1[C@H](N=C(N)N)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@H]1[C@H](N=C(N)N)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]1O QTENRWWVYAAPBI-YZTFXSNBSA-N 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 1
- 210000002304 esc Anatomy 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000003014 totipotent stem cell Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0656—Adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/05—Animals modified by non-integrating nucleic acids, e.g. antisense, RNAi, morpholino, episomal vector, for non-therapeutic purpose
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/12—Animals modified by administration of exogenous cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/30—Bird
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/44—Thiols, e.g. mercaptoethanol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/235—Leukemia inhibitory factor [LIF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/602—Sox-2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/603—Oct-3/4
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/605—Nanog
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/608—Lin28
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1307—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Environmental Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Animal Husbandry (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Developmental Biology & Embryology (AREA)
- Veterinary Medicine (AREA)
- Transplantation (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明涉及一种高效生产类克隆鸡的方法,包括以下步骤:(1)、构建OCT4,SOX2,NANOG, LIN28四因子的慢病毒过表达载体并转染黑羽狼山鸡成纤维细胞CEF;(2)、利用诱导培养基将转染OSNL的狼山鸡成纤维细胞CEF诱导为iPSCs,对诱导形成的iPSCs进行传代并进行鉴定;(3)、利用诱导培养基将诱导形成的iPSCs进行诱导分化为PGC‑like,并进行鉴定;(4)、收集PGC‑like细胞并将其通过鸡胚血管注射的方法注射至孵化2.5天的隐性白羽鸡胚血管中,并通过冰冻切片方法确定PGC‑like能够在受体隐性白羽鸡中的迁移归巢;(5)、将注射黑羽狼山鸡PGC‑like细胞的隐性白羽受体鸡胚继续孵化至至出壳。通过微卫星技术证明黑羽后代来源于供体的PGC‑like细胞。通过本发明,可大量生产与供体遗传特征相同的类克隆鸡。
Description
技术领域
本发明涉及一种高效生产类克隆鸡的方法,属于生物技术领域。
背景技术
体细胞克隆技术在哺乳动物上被广泛地用来研究细胞特性,在研究基因结构和功能、基因治疗、遗传病的发生和治疗、濒危动物物种复原等方面具有巨大的应用价值。然而,这一技术在鸟类和两栖类等卵生动物上无法实施,这极大的限制了禽类科研和生产研究相关的发展。而禽类PGCs移植技术提供了一种生产类克隆鸡的替代方案。2006年,Larval等进行了鸡异体间PGCs移植并产生了后代,证明了这是目前在家禽中唯一可高效实现体细胞克隆的途径。但是,原代分离的PGCs数量较少,远不能满足实际移植时的需求,这就限制了该技术的应用。通过ESCs诱导PGCs作为解决PGCs来源的技术仍然存在获取困难、数量少的问题。而体细胞重编程可将易于获得的皮肤或组织细胞诱导为iPSCs,研究亦表明全能干细胞能够在体外被诱导形成PGCs,这能够有效的解决目前鸡PGCs难以大量获取的关键问题。但是目前在家禽上尚未有明确的技术方案,这极大的限制了克隆技术在家禽上的推广应用,需要进一步的优化和改进。
发明内容
本发明的目的就是针对上述现有问题,提供一种高效生产类克隆鸡的方法。
本发明的技术方案是:一种高效生产类克隆鸡的方法,其特征是,包括以下步骤:
(1)、构建OCT4, SOX2, NANOG, LIN28四因子的慢病毒过表达载体并转染黑羽狼山鸡成纤维细胞CEF;
(2)、利用第一诱导培养基将转染四因子的狼山鸡成纤维细胞CEF诱导为iPSCs,在诱导的第5天细胞形态发生显著变化,逐渐聚集变圆,贴壁能力下降,此时将细胞转移至丝裂霉素处理后的CEF饲养层上培养,整个诱导过程持续21天;对诱导形成的iPSCs进行传代并进行鉴定;第一诱导培养基配方为Knockout DMEM、10%FBS、0.1mmol/Lβ-巯基乙醇、1%非必需氨基酸、1000IU/mLLIF、10ng/mLbFGF、5ng/mL SCF、1%的青链霉素、2%鸡血清;
(3)、利用第二诱导培养基将诱导形成的iPSCs进行诱导分化为PGC-like,并通过PAS糖原染色、间接免疫荧光进行鉴定;第二诱导培养基配方为基础因子培养基、40ng/mlBMP4、40ng/ml BMP8b 、50ng/ml EGF;
(4)、收集PGC-like细胞并将其通过鸡胚血管注射的方法注射至孵化2.5天的隐性白羽鸡胚血管中,并通过冰冻切片方法确定PGC-like能够在受体隐性白羽鸡中的迁移归巢;
(5)、将注射黑羽狼山鸡PGC-like细胞的隐性白羽受体鸡胚继续孵化至至出壳,即,F0代;饲养至性成熟并进行相互交配,收集种蛋并进行孵化,获得黑羽后代,并通过微卫星技术证明黑羽后代来源于供体的PGC-like细胞,至此完成类克隆鸡的生产。
步骤(2)中,对诱导形成的iPSCs进行传代并通过间接免疫荧光、碱性磷酸酶染色、染色体核型分析方法进行鉴定。
步骤(3)中,利用第二诱导培养基将诱导形成的iPSCs进行诱导分化为PGC-like,并通过PAS糖原染色、间接免疫荧光进行鉴定。
本发明方法先进科学,通过本发明,使用体细胞重编程的方法大量获得PGC-like细胞,高效生产嵌合体鸡的方法,弥补了禽类无法体细胞克隆的缺陷,为濒危物种的恢复以及物种资源保护等工作提供新思路。本方法适用于将鸡胚成纤维细胞重编程并定向诱导,类克隆鸡和嵌合体制备。采用本方法,可大量生产与供体遗传特征相同的类克隆鸡,解决克隆技术在禽类上应用困难的问题。通过本发明,在方法上,包括的步骤如下:
(1)构建OCT4, SOX2, NANOG, LIN28(OSNL)四因子的慢病毒过表达载体并转染黑羽狼山鸡成纤维细胞(CEF);
(2)利用第一诱导培养基将转染OSNL的狼山鸡CEF诱导为iPSCs,在诱导的第5天细胞形态发生显著变化,逐渐聚集变圆,贴壁能力下降,此时将细胞转移至丝裂霉素处理后的CEF饲养层上培养,整个诱导过程持续21天;对诱导形成的iPSCs进行传代并通过间接免疫荧光、碱性磷酸酶染色、染色体核型分析等方法进行鉴定;
(3)利用第二诱导培养基将诱导形成的iPSCs进行诱导分化为PGC-like,并通过PAS糖原染色、间接免疫荧光进行鉴定;
(4)收集PGC-like细胞并将其通过鸡胚血管注射的方法注射至孵化2.5天的隐性白羽鸡胚血管中,并通过冰冻切片等方法确定PGC-like能够在受体隐性白羽鸡中的迁移归巢;
(5)将注射黑羽狼山鸡PGC-like细胞的隐性白羽受体鸡胚继续孵化至至出壳(F0代),饲养至性成熟并进行相互交配,收集种蛋并进行孵化,获得黑羽后代,并通过微卫星等技术证明黑羽后代来源于供体的PGC-like细胞,至此完成类克隆鸡的生产。
本发明的优越性在于:
1、本发明能够高效的将体细胞诱导为原始生殖细胞,解决其来源问题;
2、本发明生产类克隆鸡方法切实可行,可大量生产类克隆鸡,克服体细胞克隆技术在鸡上无法应用的缺陷;
3、为转基因鸡制备、濒危物种的恢复以及物种资源保护等工作提供全新的方法,在这些领域具有较大的推广生产潜能和经济效益。
附图说明
图1是本发明iPSCs的诱导过程示意图;
图2是本发明 PGC-like的诱导过程示意图;
图3是本发明PGC-like在受体中迁移的鉴定图;
图4 是本发明类克隆鸡产生的示意图。
具体实施方法
下面结合具体实施例对本发明进一步进行描述。但本发明的保护范围并不仅限于此:
一种高效生产类克隆鸡的方法,包括的步骤为:
(1)鸡OCT4, SOX2, NANOG, LIN28(OSNL)慢病毒过表达载体感染CEF;
以1.5×105/孔状态良好的黑羽狼山鸡CEF细胞量接种24孔板,用含10%FBS的DMEM进行培养;预计细胞密度为60%左右时,每孔添加300μL无血清DMEM培养基稀释后的病毒,以感染复数为10,按1:1:1:1比例混合四种病毒,聚凝胺的终浓度为5ng/mL,侵染成纤维细胞;感染6小时后添加含有5ng/mL聚凝胺的无血清DMEM培养基稀释病毒;感染24小时后更换为含有10%FBS的DMEM继续培养至72小时观察EGFP绿色荧光表达情况。
(2)鸡iPSCs细胞诱导培养方法;
将感染后的成纤维细胞在10%FBS培养基中培养至72小时。观察细胞状态,将培养基更换为诱导培养基1(Knockout DMEM+10%FBS+0.1mmol/Lβ-巯基乙醇+1%非必需氨基酸+1000IU/mLLIF+10ng/mLbFGF+5ng/mL SCF+1%的青链霉素+2%鸡血清);诱导至第5天,细胞形态发生显著变化,逐渐聚集变圆,贴壁能力下降。将细胞转移至丝裂霉素处理后的CEF饲养层上培养;根据细胞状态,每日更换一半DMEM培养基;饲养层细胞脱落后进行传代,更换新的饲养层;诱导至形成明显单克隆集落后(图1)在体式显微镜下挑取单细胞克隆集落。用accutase消化10分钟后接种于铺有饲养层细胞的96孔板;在96孔板中培养,待饲养层细胞脱落后传代至48孔板中,用同样的方法传代至24孔板中培养。
(3)鸡iPSCs传代和鉴定;
以饲养层细胞即将脱落,iPSCs细胞产生明显的细胞克隆集落为标准进行传代培养;收集iPSCs细胞的培养基上清,用PBS轻柔清洗孔板底面清除多余的血清;200μLaccutase消化液加入孔板中,37℃消化5分钟,将消化后的细胞收集,与上清一同以1000g离心8分钟;弃去上清,在细胞沉淀中加入1mL的accutase消化液消化iPSCs克隆,于37℃消化10分钟,每3分钟震荡一次;消化结束后根据孔板数量加入3倍以上体积的因子培养基稀释accutase消化液,400目滤布过滤,接种于新的饲养层上;6小时后待iPSCs细胞粘附于新的饲养层细胞后,更换新的培养基,清除死亡的饲养层细胞;通过SSEA-1间接免疫荧光,碱性磷酸酶染色,染色体核型分析对iPSCs的生物学特征进行鉴定;
(4)鸡PGC-like细胞诱导培养和鉴定;
收集培养中的iPSCs上清,用accutase消化饲养层细胞3分钟后与上清一同以1000g离心8分钟;接种于100mm培养皿中,差速贴壁45分钟,收集上清,去除iPSCs中的饲养层细胞;以5×104/孔接种iPSCs细胞于孔板中,诱导培养基成分为基础因子培养基加40ng/mL BMP4,40ng/mL BMP8b,50ng/mL EGF诱导PGC-like形成(图2),每隔12小时更换一半的诱导培养基,整个诱导过程持续4天;通过PAS糖原染色、Cvh/C-kit间接免疫荧光对PGC-like进行生物学鉴定。
(5)鸡胚血管注射;
取发育至2.5天的隐性白羽鸡种蛋,用酒精棉球小心擦拭其钝端;在钝端开口放置在体式显微镜下,找到鸡胚血管;用显微注射针向血管中注射1μL细胞悬液(5000个/μL);将20μL青链霉素溶液从开口中轻轻滴入;用医用纸胶带将开口封住,将种蛋移回孵化箱中钝端朝上孵化。
(6)冰冻切片检测鸡PGC-like细胞迁移归巢能力;
将样品放入冰冻切片托架上加入包埋剂涂抹均匀,使样品托保持平整;迅速将样品托放入液氮,冷冻固定至无气泡产生,约20秒;将冷冻固定好的样品放入冰冻切片机中使温度平衡;安装好刀片,以20μm的厚度进行修片;修到样品处后,以8μm的厚度进行切片,用载玻片附着,显微镜下观察(图3)。
(7)体细胞诱导重编程介导的转基因鸡生产;
将注射黑羽狼山鸡PGC-like细胞的隐性白羽受体鸡胚继续孵化至至出壳(F0代);F0代饲养至性成熟,公母鸡进行交配,收集种蛋(F1代)孵化;观察并记录F1代鸡出壳时羽色形状及胫色等表型性状(图4);F1代鸡1月龄时对其进行翅静脉采血,提取血液基因组进行基因组测序或微卫星检测。
Claims (3)
1.一种高效生产类克隆鸡的方法,其特征是,包括以下步骤:
(1)、构建OCT4, SOX2, NANOG, LIN28四因子的慢病毒过表达载体并转染黑羽狼山鸡成纤维细胞CEF;
(2)、利用第一诱导培养基将转染四因子的狼山鸡成纤维细胞CEF诱导为iPSCs,在诱导的第5天细胞形态发生显著变化,逐渐聚集变圆,贴壁能力下降,此时将细胞转移至丝裂霉素处理后的CEF饲养层上培养,整个诱导过程持续21天;对诱导形成的iPSCs进行传代并进行鉴定;第一诱导培养基配方为Knockout DMEM、10%FBS、0.1mmol/Lβ-巯基乙醇、1%非必需氨基酸、1000IU/mLLIF、10ng/mLbFGF、5ng/mL SCF、1%的青链霉素、2%鸡血清;
(3)、利用第二诱导培养基将诱导形成的iPSCs进行诱导分化为PGC-like,并通过PAS糖原染色、间接免疫荧光进行鉴定;第二诱导培养基配方为基础因子培养基、40ng/ml BMP4、40ng/ml BMP8b 、50ng/ml EGF;
(4)、收集PGC-like细胞并将其通过鸡胚血管注射的方法注射至孵化2.5天的隐性白羽鸡胚血管中,并通过冰冻切片方法确定PGC-like能够在受体隐性白羽鸡中的迁移归巢;
(5)、将注射黑羽狼山鸡PGC-like细胞的隐性白羽受体鸡胚继续孵化至至出壳,即,F0代;饲养至性成熟并进行相互交配,收集种蛋并进行孵化,获得黑羽后代,并通过微卫星技术证明黑羽后代来源于供体的PGC-like细胞,至此完成类克隆鸡的生产。
2.根据权利要求1所述的一种高效生产类克隆鸡的方法,其特征是,步骤(2)中,对诱导形成的iPSCs进行传代并通过间接免疫荧光、碱性磷酸酶染色以及染色体核型分析方法进行鉴定。
3.根据权利要求1所述的一种高效生产类克隆鸡的方法,其特征是,步骤(3)中,利用第二诱导培养基将诱导形成的iPSCs进行诱导分化为PGC-like,并通过PAS糖原染色和间接免疫荧光进行鉴定。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110654978.XA CN113355359A (zh) | 2021-06-11 | 2021-06-11 | 一种高效生产类克隆鸡的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110654978.XA CN113355359A (zh) | 2021-06-11 | 2021-06-11 | 一种高效生产类克隆鸡的方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113355359A true CN113355359A (zh) | 2021-09-07 |
Family
ID=77533991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110654978.XA Pending CN113355359A (zh) | 2021-06-11 | 2021-06-11 | 一种高效生产类克隆鸡的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113355359A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111534481A (zh) * | 2020-05-18 | 2020-08-14 | 扬州大学 | 一种提高鸡胚成纤维细胞体外诱导重编程为iPS细胞效率的方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999006534A1 (en) * | 1997-08-04 | 1999-02-11 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, Represented By Its Amherst Campus | Production of avian embryonic germ (eg) cell lines by prolonged culturing of pgcs, use thereof for cloning and chimerization |
US20140363467A1 (en) * | 2011-06-10 | 2014-12-11 | University Of Georgia Research Foundation, Inc. | Avian induced pluripotent stem cells and their use |
CN110205299A (zh) * | 2019-06-14 | 2019-09-06 | 扬州大学 | 一种新型鸡cef重编程为pgc的诱导体系的建立方法 |
CN110283894A (zh) * | 2019-06-26 | 2019-09-27 | 扬州大学 | 一种通过羽色结合分子遗传标记鉴别pgc移植后代鸡的鉴定方法 |
-
2021
- 2021-06-11 CN CN202110654978.XA patent/CN113355359A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999006534A1 (en) * | 1997-08-04 | 1999-02-11 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, Represented By Its Amherst Campus | Production of avian embryonic germ (eg) cell lines by prolonged culturing of pgcs, use thereof for cloning and chimerization |
US20140363467A1 (en) * | 2011-06-10 | 2014-12-11 | University Of Georgia Research Foundation, Inc. | Avian induced pluripotent stem cells and their use |
CN110205299A (zh) * | 2019-06-14 | 2019-09-06 | 扬州大学 | 一种新型鸡cef重编程为pgc的诱导体系的建立方法 |
CN110283894A (zh) * | 2019-06-26 | 2019-09-27 | 扬州大学 | 一种通过羽色结合分子遗传标记鉴别pgc移植后代鸡的鉴定方法 |
Non-Patent Citations (1)
Title |
---|
RUIFENG ZHAO等: "Production of viable chicken by allogeneic transplantation of primordial germ cells induced from somatic cells", 《NAT COMMUN》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111534481A (zh) * | 2020-05-18 | 2020-08-14 | 扬州大学 | 一种提高鸡胚成纤维细胞体外诱导重编程为iPS细胞效率的方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2360595T3 (es) | Medio de cultivo de células embrionarias totipotentes aviares. | |
RU2426784C2 (ru) | Способ селекции кардиомиоцитов (варианты) | |
US6156569A (en) | Prolonged culturing of avian primordial germ cells (PGCs) using specific growth factors, use thereof to produce chimeric avians | |
JP2003506076A5 (zh) | ||
AU738357B2 (en) | Production of avian embryonic germ (EG) cell lines by prolonged culturing of PGCS, use thereof for cloning and chimerization | |
KR20020029096A (ko) | 조류의 시원 생식 세포를 이용한 미분화된 조류 세포 배양생산 방법 | |
CN108384749B (zh) | 鸡性腺原始生殖细胞快速分离与建系的方法 | |
JP2002536012A (ja) | 鳥類の多能性胚性生殖細胞株 | |
US20050244958A1 (en) | Production of avian embryonic germ (EG) cell lines by prolonged culturing of PGCs, use thereof for cloning and chimerization | |
CN107760654A (zh) | 一种无血清、无饲养层的小鼠诱导多能干细胞的培养基及其方法 | |
US20040226058A1 (en) | Prolonged culturing of avian (chicken) primordial germ cells (PGCs) using specific growth factors, use thereof to produce chimeric avians (chickens) | |
CN115747140A (zh) | 一种诱导鸡胚胎干细胞分化生成原始生殖细胞的方法 | |
KR100569168B1 (ko) | 조류 정원줄기세포의 배양방법 및 이에 의해 수득한 조류정원줄기세포 | |
CN113355359A (zh) | 一种高效生产类克隆鸡的方法 | |
JP4343946B2 (ja) | 鳥類の始原生殖細胞の生殖系列転移効率の改善方法 | |
CN111304156A (zh) | 一种诱导型滋养层干细胞及其制备方法和应用 | |
CN112553258A (zh) | 一种鸡成纤维细胞转分化为原始生殖细胞介导生产转基因鸡的方法 | |
CN109342153A (zh) | 一种水牛精原干细胞样细胞的免疫荧光染色方法 | |
CN107236703B (zh) | 一种饲养层细胞、培养方法及应用 | |
CN113249303B (zh) | 血管内皮细胞生长因子在促进鸡原始生殖细胞增殖和迁移中的应用 | |
CN114410572A (zh) | 一种从鸡胚血中快速分离高纯度原始生殖细胞的方法 | |
WO1996006160A1 (fr) | Procede de culture de cellules aviaires et lignee cellulaire ainsi obtenue | |
CN113337456A (zh) | 诱导分化培养基以及多能干细胞诱导分化为原始生殖细胞的方法 | |
KR20090013543A (ko) | 정조 줄기 세포의 분리방법 | |
Zhao et al. | Production of clone-like chicken by primordial germ cells induced from somatic cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210907 |
|
RJ01 | Rejection of invention patent application after publication |